RPG Life Sciences Limited (BOM: 532983)
India
· Delayed Price · Currency is INR 2,163.20
0.00 (0.00%)
At close: Dec 24, 2024
RPG Life Sciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 706.6 | 876.6 | 676.4 | 514.8 | 400 | 290.1 | Upgrade
|
| Depreciation & Amortization | 186.1 | 164.5 | 146.9 | 148.5 | 157.3 | 155.7 | Upgrade
|
| Other Amortization | 6.2 | 6.2 | 8.1 | 8.1 | 7.4 | 7.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.8 | -0.1 | 7.8 | - | 0.1 | 1.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 53.2 | Upgrade
|
| Loss (Gain) From Sale of Investments | -60.7 | -57.7 | -14.4 | -8.9 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -4.1 | 27 | 5 | 0.9 | 0.8 | - | Upgrade
|
| Other Operating Activities | -20 | -2 | -32.1 | 15.2 | 52.4 | 17.4 | Upgrade
|
| Change in Accounts Receivable | -257.1 | -142.5 | -54 | 248.1 | 62.2 | -235.3 | Upgrade
|
| Change in Inventory | 14.1 | -59.5 | -120.6 | -246.6 | -117.2 | -55.7 | Upgrade
|
| Change in Accounts Payable | 3.3 | 63.3 | 192.6 | -19.1 | 31.2 | 193.3 | Upgrade
|
| Change in Other Net Operating Assets | 490.9 | 67.8 | 92.5 | -13.5 | -11.5 | 74 | Upgrade
|
| Operating Cash Flow | 1,065 | 943.6 | 908.2 | 647.5 | 582.7 | 501.7 | Upgrade
|
| Operating Cash Flow Growth | 18.85% | 3.90% | 40.26% | 11.12% | 16.15% | 9.59% | Upgrade
|
| Capital Expenditures | -620.7 | -692.3 | -327.3 | -239.5 | -85.1 | -107.4 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.6 | 1.5 | 0.8 | - | 0.5 | 0.4 | Upgrade
|
| Investment in Securities | -79 | -269.6 | -569.9 | -119.7 | - | - | Upgrade
|
| Other Investing Activities | -145.3 | 168.9 | -161.7 | 12.6 | 5 | - | Upgrade
|
| Investing Cash Flow | -843.4 | -791.5 | -1,058 | -346.6 | -79.6 | -107 | Upgrade
|
| Short-Term Debt Repaid | - | - | -2.7 | -3.1 | -46 | -239.2 | Upgrade
|
| Long-Term Debt Repaid | - | -0.1 | -6.6 | -7.7 | -51 | -8.9 | Upgrade
|
| Total Debt Repaid | - | -0.1 | -9.3 | -10.8 | -97 | -248.1 | Upgrade
|
| Net Debt Issued (Repaid) | - | -0.1 | -9.3 | -10.8 | -97 | -248.1 | Upgrade
|
| Common Dividends Paid | -264.6 | -198.5 | -158.8 | -119.1 | - | -105.9 | Upgrade
|
| Other Financing Activities | -6.9 | -4.5 | -3.1 | -5.2 | -7.9 | -39 | Upgrade
|
| Financing Cash Flow | -271.5 | -203.1 | -171.2 | -135.1 | -104.9 | -393 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0.1 | - | - | - | Upgrade
|
| Net Cash Flow | -50.4 | -51 | -321.2 | 165.8 | 398.2 | 1.7 | Upgrade
|
| Free Cash Flow | 443.8 | 251.3 | 580.9 | 408 | 497.6 | 394.3 | Upgrade
|
| Free Cash Flow Growth | 25.47% | -56.74% | 42.38% | -18.01% | 26.20% | 51.07% | Upgrade
|
| Free Cash Flow Margin | 7.18% | 4.32% | 11.33% | 9.27% | 12.79% | 10.50% | Upgrade
|
| Free Cash Flow Per Share | 26.83 | 15.19 | 35.12 | 24.67 | 30.09 | 23.84 | Upgrade
|
| Cash Interest Paid | 6.9 | 4.5 | 3.1 | 5.2 | 7.9 | 17.2 | Upgrade
|
| Cash Income Tax Paid | 344.7 | 293.1 | 252.3 | 188.5 | 83.3 | 86.1 | Upgrade
|
| Levered Free Cash Flow | 472.89 | 222.04 | 487.99 | 350.38 | 367.74 | 273.4 | Upgrade
|
| Unlevered Free Cash Flow | 476.64 | 224.85 | 489.93 | 353.63 | 372.68 | 284.34 | Upgrade
|
| Change in Net Working Capital | -127.6 | -52.2 | -111.6 | 5.6 | 42.3 | 40.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.